SelectQuote

SLQTNYSEUSD

THESIS ALERT

Email me when the SLQT thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$0.51
+$0.05 (+10.89%)Today 1M +27.65%
After hours$0.52+3.16%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$0.46
Prior regular-session close from the quote source.
$0.50–$0.60
Regular-session low and high so far today.
2.5M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 4 projected
Projected for 2027-02-04 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$0.30–$1.76
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own SLQT if its direct-to-consumer platform keeps converting complex insurance demand into policies while proving that growth now produces cash, not just accounting revenue.

SLQT price history

Latest price$0.51Today+$0.05 (+10.89%)
SLQT +46.70%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Consumers and carriers continue to need a scaled direct-to-consumer intermediary for complex insurance shopping, so SelectQuote can keep converting demand into policy and healthcare-service volume.StrengtheningMateriality: High

    GAAP annual revenue increased from $1.003 billion in FY2023 to $1.322 billion in FY2024 and $1.527 billion in FY2025. If this holds, SelectQuote has a real demand engine; if carriers or consumers bypass it, the revenue base becomes much less durable.

    Watch: Major Medicare Advantage carriers such as UnitedHealth or Humana materially reduce broker commissions or shift enrollment volumes to proprietary direct channels.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue increased from $1.003 billion in FY2023 to $1.322 billion in FY2024 and $1.527 billion in FY2025.

    Open source ↗
  • The technology-enabled distribution model only works if SelectQuote’s lead sourcing, agent productivity, and policy persistency offset rising acquisition costs; otherwise incremental volume dilutes gross economics.WeakeningMateriality: High

    Estimated GAAP annual gross profit was $896.3 million in FY2025, a large absolute pool of economics on $1.527 billion of revenue. This determines whether growth is high-quality or merely purchased at unattractive unit economics.

    Watch: Google, Meta, affiliate marketers, or lead aggregators raise the cost of insurance leads faster than SelectQuote can improve conversion.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Estimated GAAP annual gross profit was $896.3 million in FY2025, a large absolute pool of economics on $1.527 billion of.

    Open source ↗
  • After the post-FY2022 reset, SelectQuote’s platform should show operating leverage as agent capacity, compliance infrastructure, and technology costs are spread over more productive policy volume.HoldingMateriality: Medium

    GAAP annual operating income improved from a loss of $346.0 million in FY2022 to income of $11.6 million in FY2023, $64.6 million in FY2024, and $68.5 million in FY2025. If operating leverage appears, earnings power can compound faster than revenue; if not, the platform is less scalable than advertised.

    Watch: Compliance, quality-assurance, and call-center requirements rise because of CMS scrutiny or consumer-protection rules.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income improved from a loss of $346.0 million in FY2022 to income of $11.6 million in FY2023.

    Open source ↗
  • SelectQuote’s commission and healthcare-service model must shorten the cash-payback cycle enough that policy growth funds itself rather than consuming working capital.WeakeningMateriality: Medium

    GAAP annual operating cash flow improved materially from negative $338.3 million in FY2022 to negative $19.4 million in FY2023 and positive $15.2 million in FY2024. Cash conversion is the difference between a valuable broker platform and a business that needs external capital to grow.

    Watch: Carrier payment timing, commission receivables, or chargebacks worsen as newer policy cohorts mature.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow improved materially from negative $338.3 million in FY2022 to negative $19.4 million in FY2023 and.

    Open source ↗
  • The turnaround requires balance-sheet pressure to keep easing so lenders and liquidity needs do not capture the economics before shareholders do.HoldingMateriality: Medium

    GAAP liabilities declined from $877.1 million at FY2024 year-end to $673.8 million at FY2025 year-end. Even a recovering operating business can fail equity holders if debt, refinancing, or dilution absorbs the upside.

    Watch: A refinancing or covenant amendment occurs on punitive terms because cash generation remains weak.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP liabilities declined from $877.1 million at FY2024 year-end to $673.8 million at FY2025 year-end.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Consumers and carriers continue to need a scaled direct-to-consumer intermediary for complex insurance shopping, so SelectQuote can keep converting demand into policy and healthcare-service volume. If this holds, SelectQuote has a real demand engine; if carriers or consumers bypass it, the revenue base becomes much less durable.

The technology-enabled distribution model only works if SelectQuote’s lead sourcing, agent productivity, and policy persistency offset rising acquisition costs; otherwise incremental volume dilutes gross economics. This determines whether growth is high-quality or merely purchased at unattractive unit economics.

After the post-FY2022 reset, SelectQuote’s platform should show operating leverage as agent capacity, compliance infrastructure, and technology costs are spread over more productive policy volume. If operating leverage appears, earnings power can compound faster than revenue; if not, the platform is less scalable than advertised.

SelectQuote’s commission and healthcare-service model must shorten the cash-payback cycle enough that policy growth funds itself rather than consuming working capital. Cash conversion is the difference between a valuable broker platform and a business that needs external capital to grow.

The turnaround requires balance-sheet pressure to keep easing so lenders and liquidity needs do not capture the economics before shareholders do. Even a recovering operating business can fail equity holders if debt, refinancing, or dilution absorbs the upside.

All standing thesis claims
Original report summary

its direct-to-consumer platform keeps converting complex insurance demand into policies while proving that growth now produces cash, not just accounting revenue.

Evidence assessed Oct 24, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for SelectQuote

Where the evidence on SelectQuote disagrees: Mixed on the latest evidence (Oct 24, 2026). Of its 5 thesis points, 1 strengthening, 2 holding and 2 weakening.

Bull case: what the evidence supports

  • Consumers and carriers continue to need a scaled direct-to-consumer intermediary for complex insurance shopping, so SelectQuote can keep converting demand into policy and healthcare-service volume.

    sec.gov ↗

  • After the post-FY2022 reset, SelectQuote’s platform should show operating leverage as agent capacity, compliance infrastructure, and technology costs are spread over more productive policy volume.

    sec.gov ↗

  • The turnaround requires balance-sheet pressure to keep easing so lenders and liquidity needs do not capture the economics before shareholders do.

    sec.gov ↗

Bear case: what the evidence questions

  • The technology-enabled distribution model only works if SelectQuote’s lead sourcing, agent productivity, and policy persistency offset rising acquisition costs; otherwise incremental volume dilutes gross economics.

    sec.gov ↗

  • SelectQuote’s commission and healthcare-service model must shorten the cash-payback cycle enough that policy growth funds itself rather than consuming working capital.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · SelectQuote

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed SelectQuote’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    SelectQuote filed an SEC 8-K on 2026-08-25: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    SelectQuote filed an SEC 8-K on 2026-05-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Major Medicare Advantage carriers such as UnitedHealth or Humana materially reduce broker commissions or shift enrollment volumes to proprietary direct channels.
  • Google, Meta, affiliate marketers, or lead aggregators raise the cost of insurance leads faster than SelectQuote can improve conversion.
  • Compliance, quality-assurance, and call-center requirements rise because of CMS scrutiny or consumer-protection rules.
  • Carrier payment timing, commission receivables, or chargebacks worsen as newer policy cohorts mature.
  • A refinancing or covenant amendment occurs on punitive terms because cash generation remains weak.

SLQT news

Loading headlines…

Financial statements

SLQT income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

SLQT: quick answers

When does SelectQuote (SLQT) report earnings next?
SelectQuote's next results are projected for February 4, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 4, 2026. Earnings calendar
What is SLQT's short interest?
As of October 30, 2026, 2.1M SLQT shares were sold short, 1.16% of its shares outstanding, up 40.2% from the count before. At the stock's average daily volume that is 1.4 days to cover. FINRA publishes the count twice a month. SLQT short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.